Protection Against Severe Clinical Outcomes With Adenovirus or Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Patients Hospitalized With Coronavirus Disease 2019.

Llibre, Josep M; Revollo, Boris; Aguilar, Sergi; Calomarde-Gomez, Cristina; Bruguera, Andreu; Martin-Iguacel, Raquel

Llibre, Josep M; Revollo, Boris; Aguilar, Sergi; Calomarde-Gomez, Cristina; Bruguera, Andreu; Martin-Iguacel, Raquel.

Afiliação

Llibre JM; Infectious Diseases Division, University Hospital Germans Trias, Badalona, Spain.
Revollo B; Fight AIDS and Infectious Diseases Foundation, Badalona, Spain.
Aguilar S; Infectious Diseases Division, University Hospital Germans Trias, Badalona, Spain.
Calomarde-Gomez C; Fight AIDS and Infectious Diseases Foundation, Badalona, Spain.
Bruguera A; Internal Medicine, University Hospital Germans Trias, Badalona, Spain.
Martin-Iguacel R; Rheumatology Department, University Hospital Germans Trias, Badalona, Spain.

J Infect Dis ; 226(5): 938-940, 2022 09 13.

Article em En | MEDLINE | ID: mdl-35763360

Assuntos

COVID-19; SARS-CoV-2; Adenoviridae/genética; COVID-19/prevenção & controle; Vacinas contra COVID-19; Humanos; RNA Mensageiro; SARS-CoV-2/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google